[go: up one dir, main page]

DE60004833D1 - Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung - Google Patents

Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung

Info

Publication number
DE60004833D1
DE60004833D1 DE60004833T DE60004833T DE60004833D1 DE 60004833 D1 DE60004833 D1 DE 60004833D1 DE 60004833 T DE60004833 T DE 60004833T DE 60004833 T DE60004833 T DE 60004833T DE 60004833 D1 DE60004833 D1 DE 60004833D1
Authority
DE
Germany
Prior art keywords
buspiron
pharmaceutical composition
composition containing
analgetic effect
containing paracetamol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60004833T
Other languages
English (en)
Other versions
DE60004833T2 (de
Inventor
Francoise Camborde
Alix Cloarec
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb SARL
Original Assignee
UPSA SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UPSA SAS filed Critical UPSA SAS
Application granted granted Critical
Publication of DE60004833D1 publication Critical patent/DE60004833D1/de
Publication of DE60004833T2 publication Critical patent/DE60004833T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60004833T 1999-06-30 2000-06-29 Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung Expired - Fee Related DE60004833T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9908363 1999-06-30
FR9908363A FR2795645B1 (fr) 1999-06-30 1999-06-30 Nouvelle association pharmaceutique a activite analgesique
PCT/FR2000/001817 WO2001001989A1 (fr) 1999-06-30 2000-06-29 Nouvelle association pharmaceutique a activite analgesique contenant du paracetamol et de la buspirone

Publications (2)

Publication Number Publication Date
DE60004833D1 true DE60004833D1 (de) 2003-10-02
DE60004833T2 DE60004833T2 (de) 2004-08-12

Family

ID=9547486

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60004833T Expired - Fee Related DE60004833T2 (de) 1999-06-30 2000-06-29 Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung

Country Status (14)

Country Link
US (1) US6511982B2 (de)
EP (1) EP1189617B1 (de)
JP (1) JP2003503459A (de)
AT (1) ATE247965T1 (de)
AU (1) AU780341B2 (de)
CA (1) CA2373877A1 (de)
DE (1) DE60004833T2 (de)
EC (1) ECSP013869A (de)
ES (1) ES2204663T3 (de)
FR (1) FR2795645B1 (de)
HK (1) HK1046847B (de)
MX (1) MXPA01013403A (de)
TW (1) TW577741B (de)
WO (1) WO2001001989A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593331B2 (en) 2001-04-17 2003-07-15 Laboratories Upsa Method for treatment of pain
ATE555656T1 (de) * 2005-08-19 2012-05-15 Univ California Verwendung von seh-hemmern als analgetika
US20070254960A1 (en) * 2006-04-28 2007-11-01 Gruenenthal Gmbh Pharmaceutical combination
US20120148547A1 (en) * 2009-09-01 2012-06-14 Hadasit Medical Reasearch Services & Development Ltd. Combination of vitamin e and beta-glycosphingolipids in compositions and methods for preventing and treating hepatic disorders
BR112016014611A8 (pt) 2013-12-24 2023-05-09 Univ Virginia Commonwealth Usos de sulfatos de colesterol oxigenados (ocs)
WO2016133788A1 (en) 2015-02-20 2016-08-25 The Regents Of The University Of California Methods of inhibiting pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182763A (en) 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
IN158970B (de) * 1981-06-09 1987-02-28 Ici Plc
EP0093521B1 (de) * 1982-05-04 1988-08-24 Imperial Chemical Industries Plc Chinolinderivate
US4794112A (en) 1982-12-09 1988-12-27 Cooper Stephen A Acetaminophen/hydroxyzine analgesic combinations
GB8308601D0 (en) * 1983-03-29 1983-05-05 Ici Plc Heterocyclic compounds
GB2222768B (en) 1988-06-17 1992-01-22 Nat Res Dev Analgesic compounds and compositions
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
US5872145A (en) 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
JPH10194996A (ja) * 1996-12-25 1998-07-28 Janssen Pharmaceut Nv アシル化シクロデキストリン含有製薬組成物

Also Published As

Publication number Publication date
ATE247965T1 (de) 2003-09-15
TW577741B (en) 2004-03-01
WO2001001989A1 (fr) 2001-01-11
EP1189617B1 (de) 2003-08-27
FR2795645B1 (fr) 2001-09-21
DE60004833T2 (de) 2004-08-12
AU6288500A (en) 2001-01-22
US6511982B2 (en) 2003-01-28
JP2003503459A (ja) 2003-01-28
FR2795645A1 (fr) 2001-01-05
ECSP013869A (es) 2002-09-27
MXPA01013403A (es) 2002-12-05
ES2204663T3 (es) 2004-05-01
CA2373877A1 (fr) 2001-01-11
US20010016584A1 (en) 2001-08-23
EP1189617A1 (de) 2002-03-27
HK1046847B (zh) 2004-11-26
AU780341B2 (en) 2005-03-17
HK1046847A1 (en) 2003-01-30

Similar Documents

Publication Publication Date Title
ATE423560T1 (de) Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
BR0311443A (pt) Método e dispositivo para controlar farmacocinética de droga
MY119403A (en) Novel compounds with analgesic effect.
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
BR0109150A (pt) Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente
TR200002786T2 (tr) Meloksikam için yeni galenik bir formülasyon.
ATE216879T1 (de) Verwendung von benzhydrylsulfinylderivaten zur behandlung der schläfigkeit medikamentösen ursprungs
DE60322436D1 (de) Verabreichung von capsaicinoiden
ATE301994T1 (de) Verfahren zur erleichterung von schmerzen durch eine kombination von tramadol und einen nmda- antagonist
BRPI0409523A (pt) método para o tratamento da dor neuropática, método de identificação de um composto e composição farmacêutica
SE9900961D0 (sv) Novel compounds
WO2004091540A3 (en) Methods of treating pain and compositions for use therefor
SE9802208D0 (sv) Novel compounds
DK1140198T3 (da) Anvendelse af hyaluronan til fremstilling af et lægemiddel til forögelse af cytotoksiske lægemidlers virkningsgrad
ITTO981046A0 (it) Corredo di siringa ed aghi coordinati, per iniezioni, specialmente per anestesia odontoiatrica.
BR0008402A (pt) Usos de doxepina, cloridreto de doxepina ou um metabólito de doxepina ou cloridreto de doxepina, e de um tca, composição farmacêutica, métodos para prover um tratamento analgésico, e para melhorar a dor profunda localizada ou interna
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
DE60004833D1 (de) Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung
SE9802209D0 (sv) Novel compounds
DK0799618T3 (da) Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer
DK0871446T3 (da) Anvendelse af eliprodil til fremstilling af et lægemiddel til behandling af ischaemiske sygdomme i nethinden eller den optiske nerve
EE03205B1 (et) Ropivakaiini kasutamine valuvaigistina kasutatava ravimpreparaadi valmistamiseks
EA200500175A1 (ru) Соль морфин-6-глюкуронида
EA200200656A1 (ru) НОВЫЕ ТЕРАПЕВТИЧЕСКИЕ КОМБИНАЦИИ (S)-2-(БЕНЗИЛАМИНОМЕТИЛ)-2,3,8,9-ТЕТРАГИДРО-7H-1,4-ДИОКСИН [2,3-е]ИНДОЛ-8-ОНА И НЕЙРОЛЕПТИКОВ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРЕДОТВРАЩЕНИЯ ПСИХОТИЧЕСКИХ РАССТРОЙСТВ
FR2818147B1 (fr) Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BRISTOL-MYERS SQUIBB, RUEIL MALMAISON, FR

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee